Stock listing

gettex:7XB0 Xbrane Biopharma AB Aktie

German listing (gettex) of Xbrane Biopharma AB · home listing Stockholm:XBRANE

Follow Xbrane Biopharma AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:XBRANE

13.00 SEK -1.15 (-8.1%)

Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:XBRANE

Past year +20.4% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
12.25 – 14.15 SEKNov 2, 2026
Volume
260,478 sharesNov 2, 2026
Market cap
267.9M SEKAt the close on Nov 2, 2026 · price × 20.61M shares outstanding
52-week range
5.42 – 20.00 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
1.22M SEKMedian day 28,406 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Xbrane Biopharma AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:XBRANE · Home13.00 SEK-1.15 (-8.1%)260,47814.1514.1512.2514.15Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:XBRANE · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
13.00-1.15-8.1%14.1514.1512.25260,478
14.15+1.15+8.8%13.8015.5013.70483,796
13.00-2.85-18.0%16.1016.1012.80621,707
15.85-1.55-8.9%17.8517.8515.40510,491
17.40+5.00+40.3%12.4020.0011.701,491,674
12.40+0.40+3.3%11.9512.9511.5565,413
12.00-0.65-5.1%12.6513.7511.6070,080
12.65-0.85-6.3%13.4513.7512.6552,650
13.50+0.50+3.8%13.2513.5012.8058,756
13.00+0.75+6.1%12.2513.5512.0052,343
12.25+0.85+7.5%11.1512.4011.1531,526
11.40+0.20+1.8%11.1011.5511.0029,098
11.20-0.45-3.9%11.6511.6511.0545,267
11.65-0.70-5.7%12.4012.4011.4573,561
12.35-0.20-1.6%12.6013.3512.3098,078
12.55-1.40-10.0%14.0014.0012.05106,050
13.95+0.60+4.5%13.4513.9513.0543,575
13.35-0.15-1.1%13.4013.5012.5030,156
13.50-0.70-4.9%14.2014.2012.80133,180
14.20+1.70+13.6%12.4514.2512.45234,066
12.50+2.10+20.2%10.4012.5010.40204,685
10.40-0.15-1.4%10.5010.8510.3018,246
10.55-0.45-4.1%11.0011.0010.5017,765
11.00-0.10-0.9%11.0011.1010.7514,364
11.10+0.65+6.2%10.4511.1010.4521,362
10.45-0.15-1.4%10.7511.0010.3561,964
10.60+0.20+1.9%10.4010.8510.4027,216
10.40-0.20-1.9%10.6010.6010.2514,635
10.60+0.30+2.9%10.3510.7510.359,654
10.30-0.35-3.3%10.5510.6510.2011,387
10.65+0.55+5.4%10.1010.8010.1010,300
10.10-0.10-1.0%10.2010.3510.106,365
10.20-0.15-1.4%10.0010.5510.0013,605
10.35+0.05+0.5%10.3010.359.9221,916
10.300.000.0%10.2510.309.9033,400
10.30+0.20+2.0%10.2010.359.9017,203
10.10-0.35-3.3%10.4510.7010.1028,927
10.45-0.25-2.3%10.6010.8010.4017,242
10.70-0.10-0.9%10.8010.9010.5538,854
10.80+0.50+4.9%10.4510.9010.4027,885
10.30+0.54+5.5%9.7810.909.78101,500
9.76-0.24-2.4%9.9010.309.7620,232
10.000.000.0%10.0010.409.8413,730
10.00+0.42+4.4%9.5810.009.4219,877
9.58+0.08+0.8%9.589.589.4214,655
9.500.000.0%9.409.589.0422,309
9.50+0.22+2.4%9.509.589.2019,238
9.28+0.10+1.1%9.209.509.148,689
9.18-0.18-1.9%9.389.709.1029,569
9.36-0.14-1.5%9.509.709.2834,437
9.500.000.0%9.489.509.2021,167
9.50-0.06-0.6%9.589.609.1840,545
9.56-0.04-0.4%9.5210.009.3831,380
9.60-0.06-0.6%9.449.869.4444,764
9.66-0.32-3.2%9.8610.309.4024,213
9.98+0.24+2.5%9.7410.009.4459,730
9.74+0.18+1.9%9.609.809.4219,892
9.56-0.16-1.6%9.729.769.4425,733
9.72+0.14+1.5%9.589.849.5621,347
9.58-0.57-5.6%10.1510.159.5039,876
10.15+0.15+1.5%10.0510.159.9610,671
10.00-0.10-1.0%9.9810.109.8620,761
10.100.000.0%9.9610.209.962,686
10.10-0.05-0.5%10.0010.209.9213,829
10.15-0.10-1.0%10.2510.259.8612,395
10.25+0.10+1.0%9.9810.309.945,118
Ticker
gettex:7XB0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Xbrane Biopharma (Stockholm:XBRANE) Q2 2026 Earnings Call

    Fri, Jul 17, 2026 · 3:00 AM ET

    Watch Transcript

  • Xbrane Biopharma (Stockholm:XBRANE) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 3:00 AM ET

    Watch Transcript

  • Xbrane Biopharma (Stockholm:XBRANE) Q4 2025 Earnings Call

    Fri, Feb 20, 2026 · 7:00 AM ET

    Watch Transcript

Latest news

Xbrane Biopharma releases Interim Report for January-June 2026

Jul 17, 2026

Closed 10.60 (-0.9%) on Jul 17, 2026

Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane – Xbrane´s Biosimilar Candidate to Darzalex® (Daratumumab)

Jun 11, 2026

Closed 10.70 (0.0%) on Jun 12, 2026

Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) receives FDA BsUFA date of October 29, 2026 for its investigational biosimilar candidate to LUCENTIS® (ranibizumab)

Jun 3, 2026

Closed 10.60 (+7.1%) on Jun 4, 2026

Xbrane and its partner Intas agree on revised financing arrangement for Xbrane’s Xdivane development activities

May 5, 2026

Closed 9.72 (-1.6%) on May 5, 2026

XBRANE submits ranibizumab biosimilar candidate to FDA

Apr 30, 2026

Closed 11.00 (+10.0%) on Apr 30, 2026

Xbrane provides an update on the timeline for resubmission of the market authorization application in the United States

Mar 31, 2026

Closed 6.68 (+5.2%) on Apr 1, 2026

Xbrane has released the company's 2025 Annual and Sustainability Report. The report summarizes business, financial performance and work on sustainability.

Mar 31, 2026

Closed 6.35 (+5.5%) on Mar 31, 2026

Xbrane Biopharma releases Year-end Report 2025

Feb 20, 2026

Closed 8.70 (-13.0%) on Feb 20, 2026

Xbrane Biopharma resolves to issue 420,517 warrants to Fenja Capital II A/S under the conditional financing solution

Nov 24, 2025

Closed 9.81 (+12.1%) on Nov 25, 2025

XBRANE updates on timing for resubmission of the BLA for its ranibizumab biosimilar candidate to FDA

Nov 19, 2025

Closed 9.49 (-4.7%) on Nov 19, 2025

All Xbrane Biopharma AB news

Decks

Xbrane Biopharma AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 12 in all · newest Jul 17, 2026 · oldest 2025
Calls
10 calls with a replay · 10 with a transcript · latest Jul 17, 2026
Decks
17 decks · latest Oct 30, 2026

Where Xbrane Biopharma AB is listed

ListingExchangeCountryCurrency
Stockholm:XBRANE · Home listingStockholmSwedenSEK
gettex:7XB0 · This pagegettexGermanyEUR
LS Exchange:A41PJJLS ExchangeGermanyEUR
Lang & Schwarz:A41PJJLang & SchwarzGermanyEUR
Aquis:XBRANSAquisUnited KingdomSEK
Aquis:XBRANSAquisUnited KingdomSEK
Frankfurt:7XB0FrankfurtGermanyEUR
Munich:7XB0MunichGermanyEUR
Stuttgart:7XB0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Xbrane Biopharma AB.